ANTRIGAT
LIVE

Serial Number

79284567

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ANTRIGAT Trademark

Serial Number: 79284567 • Registration: 6150274

ANTRIGAT is a trademark filed by NOVARTIS AG on March 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,172 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 23, 2020

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Cancellation Date

September 22, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 12, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 11, 2023 DETH
NOTIFICATION PROCESSED BY IB
Nov 28, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 5, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 5, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 15, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 29, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 29, 2020 COAR
NOTICE OF PUBLICATION
Jun 10, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2020 CNSA
ASSIGNED TO EXAMINER
May 27, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 12, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 4, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 30, 2020 SDRC